With 90% of clinical trials failing¹ to meet FDAapproval, researchers, regulators, sponsorsand other stakeholders have worked tirelesslyto identify causes of such high failure rates;many reasons are cited, including failure tomeet statistical endpoints, insufficient patientenrollment, safety issues and failure to meetFDA protocols.
Posts by: